Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorVural B.
dc.contributor.authorAtalar F.
dc.contributor.authorCiftci C.
dc.contributor.authorDemirkan A.
dc.contributor.authorSusleyici-Duman B.
dc.contributor.authorGunay D.
dc.contributor.authorBuyukdevrim A.S.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:53:33Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:53:33Z
dc.date.issued2008
dc.identifier.issn1054-8807
dc.identifier.urihttps://dx.doi.org/10.1016/j.carpath.2008.02.006
dc.identifier.urihttp://hdl.handle.net/11446/1965
dc.descriptionPubMed ID: 18417367en_US
dc.description.abstractBackground: Metabolic syndrome is a cluster of different clinical manifestations that are risk factors for atherothrombotic cardiovascular disorders. Fatty-acid-binding protein 4 (FABP4/aP2), which is highly expressed in adipocytes, specifically exerts intracellular lipid trafficking. A high level of fatty-acid-binding protein 4 expression present in obese subjects has also been found in mice and humans, especially in macrophages at atherosclerotic lesions. An in vivo study demonstrated that the inhibitor of aP2 would be a new therapeutic agent for treating metabolic diseases in mice. We have investigated the mRNA expression of fatty-acid-binding protein 4 in human epicardial adipose and ascending aorta tissues of metabolic syndrome and nonmetabolic syndrome patients. Methods: Paired epicardial adipose and ascending aorta tissue samples were obtained from 10 metabolic syndrome patients and 4 nonmetabolic syndrome patients during coronary bypass grafting and aortic valve replacement therapy, respectively. Fatty-acid-binding protein 4 gene expression was determined by quantitative real-time polymerase chain reaction. Results and Conclusions: Fatty-acid-binding protein 4 expression of epicardial adipose tissue was significantly higher in metabolic syndrome patients than in nonmetabolic syndrome controls (P<.05). In metabolic syndrome patients, fatty-acid-binding protein 4 expression in epicardial adipose tissue was 66 times higher than fatty-acid-binding protein 4 expression in ascending aorta tissue. The expression level of fatty-acid-binding protein 4 in epicardial adipose tissue was found to be significantly correlated with waist circumference in all subjects (r=.535, P<.05). Our data showed for the first time that human epicardial adipose and ascending aorta tissues express fatty-acid-binding protein 4 and that its level of expression in epicardial adipose tissues of metabolic syndrome patients is elevated. Increased fatty-acid-binding protein 4 gene expression in epicardial adipose tissues of metabolic syndrome patients led us think that fatty-acid-binding protein 4 might be an important factor in metabolic syndrome. © 2008 Elsevier Inc. All rights reserved.en_US
dc.language.isoengen_US
dc.identifier.doi10.1016/j.carpath.2008.02.006en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAscending aortaen_US
dc.subjectEpicardial adipose tissueen_US
dc.subjectFABP4en_US
dc.subjectMetabolic syndromeen_US
dc.titlePresence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndromeen_US
dc.typearticleen_US
dc.relation.journalCardiovascular Pathologyen_US
dc.departmentDBÜen_US
dc.identifier.issue6en_US
dc.identifier.volume17en_US
dc.identifier.startpage392en_US
dc.identifier.endpage398en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempDBÜen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster